Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Julie L. Mitchell

Research Assistant Professor

Oregon Health & Science University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Articles (14)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

David Morrow

Oregon Health & Science University

UNITED STATES

View details

Hiroshi Takata

Staff Scientist

Oregon Health & Science University

UNITED STATES

View details

Justin Pollara

Associate Professor

Duke University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Julie L. Mitchell

Research Interests

Explore related searches

Articles (14)

Identification of cross-stage, cross-species malaria CD8+ T cell antigens

Rapid and profound decay of inducible and intact HIV genomes in early-treated Thai children

Activation of CXCR3<sup>+</sup> Tfh cells and B cells in lymph nodes during acute HIV-1 infection correlates with HIV-specific antibody development

Dynamic changes in immune cell subsets in blood and lymph node over the course of acute HIV infection.

CD4dimCD8bright T cells are inversely associated with neuro-inflammatory markers among people with HIV

Initial productive and latent HIV infections originate in vivo by infection of resting T cells

An active HIV reservoir during ART is associated with maintenance of HIV-specific CD8+ T cell magnitude and short-lived differentiation status

Long-term antiretroviral therapy initiated in acute HIV infection prevents residual dysfunction of HIV-specific CD8+ T cells

Anti-HIV antibody development up to 1 year after antiretroviral therapy initiation in acute HIV infection

CTL Clonotypes with Higher TCR Affinity Have Better Ability to Reduce the HIV Latent Reservoir

A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection.

Continuous prophylactic ARV/ART since birth reduces seeding and persistence of the viral reservoir in vertically HIV-infected children.

Plasmacytoid dendritic cells sense HIV replication before detectable viremia following treatment interruption.

Plasmacytoid dendritic cells sense HIV replication before detectable viremia following treatment interruption

Collaborators (3)

David Morrow

Hiroshi Takata

Justin Pollara

Make your next move.